These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25661473)

  • 1. The development of global vaccine stockpiles.
    Yen C; Hyde TB; Costa AJ; Fernandez K; Tam JS; Hugonnet S; Huvos AM; Duclos P; Dietz VJ; Burkholder BT
    Lancet Infect Dis; 2015 Mar; 15(3):340-7. PubMed ID: 25661473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Framework for Optimal Global Vaccine Stockpile Design for Vaccine-Preventable Diseases: Application to Measles and Cholera Vaccines as Contrasting Examples.
    Thompson KM; Duintjer Tebbens RJ
    Risk Anal; 2016 Jul; 36(7):1487-509. PubMed ID: 25109229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of vaccine stockpiling to respond to epidemics and remediate global supply shortages affecting immunization: strategic challenges and risks identified by manufacturers.
    Jarrett S; Pagliusi S; Park R; Wilmansyah T; Jadhav S; Santana PC; Krishnamurthy KR; Yang L
    Vaccine X; 2021 Dec; 9():100119. PubMed ID: 34934942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era.
    Desai SN; Pezzoli L; Alberti KP; Martin S; Costa A; Perea W; Legros D
    Hum Vaccin Immunother; 2017 Mar; 13(3):579-587. PubMed ID: 27813703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences.
    Shrestha SS; Wallace GS; Meltzer MI
    Vaccine; 2010 Aug; 28(38):6318-32. PubMed ID: 20638451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks.
    Billington J; Deschamps I; Erck SC; Gerberding JL; Hanon E; Ivol S; Shiver JW; Spencer JA; Van Hoof J
    Health Secur; 2020; 18(3):241-249. PubMed ID: 32348165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stockpile levels for pediatric vaccines: how much is enough?
    Jacobson SH; Sewell EC; Proano RA; Jokela JA
    Vaccine; 2006 Apr; 24(17):3530-7. PubMed ID: 16522344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Funding vaccines for emerging infectious diseases.
    Wong G; Qiu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1760-1762. PubMed ID: 29194012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The United States pediatric vaccine stockpile program.
    Lane KS; Chu SY; Santoli JM
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S125-9. PubMed ID: 16447134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate.
    Riley S; Wu JT; Leung GM
    PLoS Med; 2007 Jun; 4(6):e218. PubMed ID: 17579511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in and shortcomings of control strategies, drug stockpiles, and vaccine development during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans.
    Mei L; Song P; Tang Q; Shan K; Tobe RG; Selotlegeng L; Ali AH; Cheng Y; Xu L
    Biosci Trends; 2013 Apr; 7(2):64-76. PubMed ID: 23612075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to "Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences".
    Proano RA; Jacobson SH; Jokela JA
    Vaccine; 2011 Jan; 29(4):615; author reply 616. PubMed ID: 21094271
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccine shortages eliminate possibility for excess capacity in stockpiles.
    Congeni BL
    Pediatr Ann; 2004 Sep; 33(9):577-83. PubMed ID: 15462572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of the pediatric vaccine supply shortage problem.
    Jacobson SH; Sewell EC; Proano RA
    Health Care Manag Sci; 2006 Nov; 9(4):371-89. PubMed ID: 17186772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vaccine banks in resilience, response and recovery in respect of animal diseases.
    Dungu B
    Rev Sci Tech; 2020 Aug; 39(2):543-550. PubMed ID: 33046921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS).
    Oshansky CM; Zhou J; Gao Y; Schweinle JE; Biscardi K; DeBeauchamp J; Pavetto C; Wollish A; ; Webby RJ; Cioce V; Donis RO; Bright RA
    Vaccine; 2019 Jan; 37(3):435-443. PubMed ID: 30553570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging zoonotic diseases in a changed world: strategic vision or fire-fighting?
    Burgos S
    Transbound Emerg Dis; 2010 Dec; 57(6):465-7. PubMed ID: 20807392
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergency response vaccines: lessons learned in response to communicable diseases.
    Milstien J
    Expert Opin Biol Ther; 2003 Oct; 3(7):1121-31. PubMed ID: 14519076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.
    Nelson CB; Birmingham M; Costa A; Daviaud J; Perea W; Kieny MP; Tarantola D
    Am J Public Health; 2007 Apr; 97 Suppl 1(Suppl 1):S15-22. PubMed ID: 17413077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Should Resources From National Stockpiles Be Managed?
    Hollett G; Jarrett JB
    AMA J Ethics; 2024 Apr; 26(4):E315-320. PubMed ID: 38564746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.